Immunome, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $-25.2M | $1.7M |
| FY2019 | — | $-35.6M | $2.5M |
| FY2020 | $134.0K | $41.3M | $39.8M |
| FY2021 | — | $48.2M | $49.2M |
| FY2022 | — | $16.7M | $20.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $-25.2M | $1.7M |
| FY2019 | — | $-35.6M | $2.5M |
| FY2020 | $134.0K | $41.3M | $39.8M |
| FY2021 | — | $48.2M | $49.2M |
| FY2022 | — | $16.7M | $20.3M |